| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | +6.22% | +2.22% | +4.00% | +4.00% | — |
| 14d | 1 | +0.00% | +3.83% | +1.37% | +2.45% | +2.45% | — |
| 30d | 1 | +0.00% | +9.57% | +5.95% | +3.62% | +3.62% | — |
| 60d | 1 | +0.00% | +35.41% | +5.47% | +29.94% | +29.94% | — |
| 90d | 1 | +0.00% | +88.04% | +11.16% | +76.88% | +76.88% | — |
| 180d | 1 | +0.00% | +45.45% | +15.34% | +30.11% | +30.11% | — |
| 1y | 1 | +0.00% | +32.54% | +33.72% | -1.18% | -1.18% | — |
| 2y | 1 | +0.00% | +14.35% | +44.74% | -30.38% | -30.38% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ORMP ORAMED PHARMACEUTICALS INC. | SALE Chief Scientific Officer | 435,084 | $3.31 | $1.44M | 1,133,138 | Mar 30, 2026 | Mar 31, 2026 ↗ | View → |
| LFWD LIFEWARD LTD. | PURCHASEGRANT Stock grant | 7,657 | — | — | 7,657 | Mar 25, 2026 | Mar 27, 2026 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 119,558 | — | — | 1,568,222 | Mar 17, 2026 | Mar 18, 2026 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | SALE Chief Scientific Officer | 19,000 | — | — | 0 | Jan 22, 2026 | Jan 29, 2026 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASE Chief Scientific Officer | 19,000 | — | — | 1,448,664 | Jan 22, 2026 | Jan 29, 2026 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | SALEGRANT Gift | 86,166 | — | — | 1,343,498 | Jan 14, 2026 | Jan 21, 2026 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 121,331 | — | — | 1,314,664 | Dec 31, 2025 | Jan 5, 2026 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 115,000 | — | — | 1,429,664 | Dec 31, 2025 | Jan 5, 2026 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 19,000 | — | — | 19,000 | Dec 31, 2025 | Jan 5, 2026 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 74,000 | — | — | 1,074,666 | Feb 11, 2025 | Feb 11, 2025 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 66,667 | — | — | 1,193,333 | Feb 11, 2025 | Feb 11, 2025 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 52,000 | — | — | 1,126,666 | Feb 11, 2025 | Feb 11, 2025 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 207,000 | — | — | 1,000,666 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 30,000 | — | — | 793,666 | Nov 7, 2024 | Nov 8, 2024 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 295,500 | — | — | 763,666 | Jan 4, 2024 | Jan 8, 2024 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 53,500 | — | — | 468,166 | May 26, 2023 | May 31, 2023 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 213,000 | — | — | 414,666 | Apr 17, 2023 | Apr 20, 2023 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | SALE Chief Scientific Officer | 100,000 | $2.01 | $201.0K | 201,666 | Mar 14, 2023 | Mar 15, 2023 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 34,000 | — | — | 217,666 | Jul 28, 2022 | Aug 1, 2022 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 84,000 | — | — | 301,666 | Jul 28, 2022 | Aug 1, 2022 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 42,000 | — | — | 183,666 | Jan 3, 2022 | Jan 5, 2022 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 72,000 | — | — | 72,000 | Jan 3, 2022 | Jan 5, 2022 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 66,666 | — | — | 141,666 | Aug 31, 2021 | Sep 2, 2021 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Feb 3, 2021 | Feb 8, 2021 ↗ | View → |
| ORMP ORAMED PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Jan 8, 2020 | Jan 14, 2020 ↗ | View → |